Germany's RAG Foundation could sell entire Evonik stake
Germany's RAG Foundation could sell entire Evonik stake FRANKFURT, Sept 30 (Reuters) - RAG Foundation, the largest shareholder in Evonik EVKn.DE, could sell its entire stake in the German chemicals manufacturer, it said on Wednesday.
RAG currently holds around 43% of the shares in Evonik, and in the past, has stated its intention to reduce its holding to a blocking minority of 25.1%.
Competitor BASF has recently sought to take over Evonik.
“Under the foundation's statutes, a complete disposal of Evonik is possible,” the Essen-based foundation said on Wednesday in response to a query from Reuters.
With the approval of the foundation's board of trustees, it would be possible to sell additional shares, up to and including a complete divestment, it said.
The board of trustees is dominated by politicians and trade union representatives.
(Reporting by Matthias Inverardi; writing by Tom Sims; Editing by Kirsten Donovan)
((Tom.Sims@thomsonreuters.com; +49 30 220 133 645;))
Recent news on BASF SE
See all newsDeals of the day-Mergers and acquisitions
BASF to honour Evonik's commitments on sites, jobs in case of takeover, CEO says (updated)
BASF to honour Evonik's commitments on sites, jobs in case of takeover, CEO says
Evonik considering purchase of US peer such as Ashland, Handelsblatt says
Insight: How cheap Chinese antibiotics threaten Europe's last major penicillin plant